Decreased serum levels of D-serine in patients with schizophrenia: Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia

Archives of General Psychiatry

Volumn 60, Issue 6, 2003, Pages 572-576

  Hashimoto, Kenji ^a   Fukushima, Takeshi ^b   Shimizu, Eiji ^a   Komatsu, Naoya ^a   Watanabe, Hiroyuki ^a   Shinoda, Naoyuki ^a   Nakazato, Michiko ^a   Kumakiri, Chikara ^a   Okada, Shin Ichi ^a   Hasegawa, Hisanori ^b   Imai, Kazuhiro ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO SERINE; GLUTAMATE RECEPTOR; GLYCINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RACEMASE; SERINE;

ADULT; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEASUREMENT; PATHOPHYSIOLOGY; PROTEIN FUNCTION; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BRIEF PSYCHIATRIC RATING SCALE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLYCINE; HUMANS; MALE; MIDDLE AGED; RACEMASES AND EPIMERASES; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SERINE; SEX FACTORS; STEREOISOMERISM;

EID: 0037977113     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.6.572     Document Type: Article

References (25)

1. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
2. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
3. Coyle JT. The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry. 1996;3:241-253.
4. Tamminga CA. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol. 1998;12:21-36.
5. Krystal JH, D'Souza DC, Petrakis IL, Belger A, Berman R, Charney DS, Abi-Saab W, Madonick S. NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies for neuropsychiatric disorders. Harv Rev Psychiatry. 1999;7:125-133.
6. Hashimoto K, Iyo M. Glutamate hypothesis of schizophrenia and targets for new antipsychotic drugs [in Japanese]. Nihon Shinkei Seishin Yakurigaku Zasshi. 2002; 22:3-13.
7. Imai K, Fukushima T, Santa T, Homma H, Hamase K, Sakai K, Kato M. Analytical chemistry and biochemistry of d-amino acids. Biomed Chromatogr. 1996;10:303-312.
8. Hashimoto A, Oka T. Free d-aspartate and d-serine in the mammalian brain and periphery. Prog Neurobiol. 1997;52:325-353.
9. Snyder SH, Ferris CD. Novel neurotransmitters and their neuropsychiatric relevance. Am J Psychiatry. 2000;157:1738-1751.
10. Schell MJ, Molliver ME, Snyder SH. d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci U S A. 1995;92:3948-3952.
11. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. d-Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 1998;44:1081-1089.
12. Goff DC, Coyle JT. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry. 2001;158:1367-1377.
13. Friedman M. Chemistry, nutrition, and microbiology of d-amino acids. J Agric Food Chem. 1999;47:3457-3479.
14. Fukushima T, Lee JA, Korenaga T, Ichikawa H, Kato M, Imai K. Simultaneous determination of d-lactic acid and 3-hydroxybutyric acid in rat plasma using a column-switching HPLC with fluorescent derivatization with 4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ). Biomed Chromatogr. 2001;15:189-195.
15. Huang Y, Nishikawa T, Satoh K, Iwata T, Fukushima T, Santa T, Homma H, Imai K. Urinary excretion of d-serine in human. Biol Pharm Bull. 1998;21:156-162.
16. Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall Publishers; 1991.
17. Waziri R, Baruah S, Hegwood TS, Sherman AD. Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics. Neurosci Lett. 1990; 120:237-240.
18. Waziri R, Baraiah S, Sherman AD. Abnormal serine-glycine metabolism in the brains of schizophrenics. Schizophr Res. 1993;8:233-243.
19. Dunlop DS, Neidle A. The origin and turnover of d-serine in brain. Biochem Biophys Res Commun. 1997;235:26-30.
20. Wolosker H, Sheth K, Takahashi M, Mothet JP, Brady RO, Ferris CD, Snyder SH. Purification of serine racemase. Proc Natl Acad Sci U S A. 1999;96:721-725.
21. Wolosker H, Blackshaw S, Snyder SH. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutannate N-methyl-d-aspartate neurotransmission. Proc Natl Acad Sci U S A. 1999;96:13409-13414.
22. Miranda JD, Santoro A, Engelender S, Wolosker H. Human serine racemase: molecular cloning, genomic organization and functional analysis. Gene. 2000;256:183-188.
23. Takahashi K, Hayashi F, Nishikawa T. In vivo evidence for the link between I- and d-serine metabolism in rat cerebral cortex. J Neurochem. 1997;69:1286-1290.
24. Kumashiro S, Hashimoto A, Nishikawa T. Free d-serine in post-mortem brains and spinal cords of individuals with and without neuropsychiatric diseases. Brain Res. 1995;681:117-125.
25. Tsai GE, Yang P, Chung LC, Tsai IC, Tsai CW, Coyle JT. d-Serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry. 1999;156:1822-1855.